New York 2025-2026 Regular Session

New York Assembly Bill A04929

Introduced
2/10/25  
Refer
2/10/25  

Caption

Eliminates criminal and civil penalties for possession of controlled substances; establishes the drug decriminalization task force to develop recommendations for reforming state laws, regulations and practices so that they align with the stated goal of treating substance use disorder as a disease, rather than a criminal behavior.

Summary

Bill A04929 aims to decriminalize the possession of controlled substances in New York State by eliminating criminal and civil penalties associated with personal use. The legislation recognizes substance use disorder as a public health issue rather than a criminal one, advocating for a shift in approach that focuses on treatment and support rather than punishment. It establishes a drug decriminalization task force tasked with developing recommendations for reforming state laws and practices to align with this new perspective on substance use disorders.

Impact

If enacted, this bill would significantly alter the legal landscape surrounding drug possession in New York. It would repeal existing penal law provisions that criminalize personal possession of controlled substances, thereby reducing the number of individuals incarcerated for drug-related offenses. The bill also mandates the establishment of a task force to recommend further reforms, potentially leading to broader changes in how substance use is addressed within the legal and health systems.

Sentiment

The sentiment surrounding Bill A04929 appears to be largely supportive among advocates for drug reform and public health. Discussions highlight a growing recognition of the ineffectiveness of criminalization in addressing substance use disorders and the need for compassionate, science-based approaches. However, there may be concerns from some law enforcement and community members about the implications of decriminalization on public safety and drug-related issues.

Contention

Notable points of contention may arise from differing views on the effectiveness of decriminalization. Critics may argue that eliminating penalties could lead to increased drug use and associated societal issues, while supporters emphasize the need to prioritize health and recovery over punishment. Additionally, there may be concerns about the task force's composition and the representation of various stakeholders in the reform process.

Companion Bills

NY S03600

Same As Eliminates criminal and civil penalties for possession of controlled substances; establishes the drug decriminalization task force to develop recommendations for reforming state laws, regulations and practices so that they align with the stated goal of treating substance use disorder as a disease, rather than a criminal behavior.

Previously Filed As

NY S02340

Eliminates criminal and civil penalties for possession of controlled substances; establishes the drug decriminalization task force to develop recommendations for reforming state laws, regulations and practices so that they align with the stated goal of treating substance use disorder as a disease, rather than a criminal behavior.

Similar Bills

CA AB1612

Disposition of controlled substances.

MA H2227

Replacing archaic and stigmatizing language for substance use

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1203

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.

NJ S2271

"CJ's Law"; Criminalizes manufacture and distribution of substances containing kratom under certain circumstances.